Berenberg Bank Lowers GSK (LON:GSK) Price Target to GBX 1,600

GSK (LON:GSK – Free Report) had its price objective reduced by Berenberg Bank from GBX 1,820 ($23.04) to GBX 1,600 ($20.25) in a research note published on Friday, MarketBeat reports. They currently have a buy rating on the stock. A number of other brokerages have also recently commented on GSK. Deutsche Bank Aktiengesellschaft reiterated a […]

Leave a Reply

Your email address will not be published.

Previous post Milito: Offshore energy is an untapped goldmine
Next post Xcel Brands (NASDAQ:XELB) Now Covered by StockNews.com